Gout News

Colchicine fails to significantly reduce mechanical ventilation or 28-day mortality in hospitalized patients with COVID-19 pneumonia, compared with usual care, according to data published in JAMA Network Open.

A semi-quantitative plain radiographic scoring method for assessing new bone formation in sclerosis and spur in gout is feasible, valid and reproducible, according to data published in Arthritis Research & Therapy.

Early reduction in high-sensitivity C-reactive protein is “not a good biomarker” for canakinumab’s protective impact on future gout flares, according to data published in Arthritis Care & Research.

Few randomized clinical trials support using repository corticotropin injection for most FDA-approved indications, including rheumatoid arthritis, ankylosing spondylitis, lupus, optic neuritis and nephrotic syndrome, according to researchers.

Although excess adiposity and genetic predisposition are individually strongly linked to greater gout risk, both combined result in a higher risk than the sum of each, especially in women, according to data.

Patients with type 2 diabetes who receive sodium-glucose transport protein 2 inhibitors may have a lower risk for gout compared with those using dipeptidyl peptidase 4 inhibitors, according to data published in JAMA Network Open.

Adding colchicine to the standard care regimen for COVID-19 fails to decrease disease severity or reduce the risk for death in hospitalized patients, according to a meta-analysis published in RMD Open.

The COVID-19 pandemic brought with it a significant decrease in autoimmunity laboratory testing, first rheumatology visits and diagnoses from 2019 to 2020, according to Italian data published in The Journal of Rheumatology.

A median of just 16.2% of adults with arthritis attended a self-management class in 2019, while that same year 69.3% received counseling for physical activity from their provider, according to CDC researchers.

Allopurinol is noninferior to febuxostat for gout when dosed appropriately as part of a treat-to-target strategy, according to data presented at ACR Convergence 2021.